| 摘要 |
<p>Antirheumatic agent containing, as the active ingredient, a specific glycolipid such as difucosyl neolactonoroctaosylceramide or trifucosyl neolactonoroctaosylceramide. Said glycolipids are known compounds which are isolated from human adenocarcinoma. However, up to the date, there have not been known that these glycolipids possess any pharamcological activities relating to the rheumatoid arthritis. Said antirheumatic agent may preferably be used as injectable pharmaceutical preparations.</p> |
